We are proud to be a leading scientific voice and contributor to advancements in new therapeutics and devices for metabolic diseases. As a full-service clinical research organization (CRO), we work with clients of all sizes worldwide to design and conduct multinational clinical trials, from clinical development and regulatory planning for new investigational drugs through phase 2b and including augmentation of phase 3 clinical trials.
We are widely recognized as the leading CRO for metabolic diseases. Our core competencies in science, advanced methodologies, and operations differentiate our services, as well as provide our clients an advantage in the evolving landscape of metabolic drug and device development.
Our expertise in patient engagement and clinical trials is reflected in the relationships we have with study participants who choose to partner with ProSciento because of our commitment to make a difference in the lives of patients through science, quality, and operational excellence.
We are passionate about a culture of teamwork, well-being, and the professional growth of our employees. Together, with our diverse skills and expertise, we are proud to contribute to the clinical development of life-changing therapeutics for people living with metabolic diseases.